Sr. Director, Patient Marketing Dual Asset Strategy

Key Responsibilities

• Maximize Growth trajectory and peak revenue of Vyvgart in CIDP (Primary)
  • Lead the development and evolution of patient commercial strategy to maximize growth across CIDP and MMN.
  • Identify and unlock growth levers across awareness, consideration, therapy initiation, persistence, and lifecycle management.
  • Strengthen competitive positioning and reinforce differentiated value within the treatment paradigm.
  • Drive omnichannel optimization using rigorous performance analytics and agile measurement.
  • Expand addressable market through targeted patient segment strategies and ecosystem partnerships.
  • Partner closely with HCP, Market Access, Medical, Patient Support Services and Patient Advocacy to remove friction points across the patient journey.
  • Co-Lead proactive competitive response planning and scenario modeling.
• Architect Dual-Asset Co-Positioning Strategy
  • Define clear roles, positioning, and treatment sequencing for Vyvgart and Empa across CIDP and MMN.
  • Develop a franchise-level value narrative that clarifies differentiation while reinforcing complementary strengths.
  • Prevent internal cannibalization through disciplined segmentation and treatment pathway strategy.
  • Establish guardrails for patient engagement, messaging, targeting, and lifecycle investment decisions.
  • Lead trade-off discussions to optimize enterprise value versus individual brand preference.
• Shape the Market to Expand Total Franchise Value
  • Drive market shaping initiatives that grow category awareness and demand.
  • Lead disease awareness and unbranded education strategies to increase top-of-funnel volume.
  • Identify structural barriers (diagnostic delay, access constraints, patient inertia) and design strategic interventions.
  • Influence evidence generation priorities in partnership with Medical and Development to support long-term differentiation.
  • Anticipate competitive shifts and adapt ecosystem strategy accordingly.
• Launch Integration – Second Asset Co-develop Patient Commercial Strategy for Empa MMN launch with disciplined alignment to franchise strategy.
  • Ensure Empa launch positioning complements and strengthens the in-market value of Vyvgart Hytrulo.
  • Define sequencing, patient targeting, and differentiation strategy.
  • Align US strategy with Global framework while advocating for market-specific needs.
• Enterprise & Strategic Leadership
  • Serve as a core strategic voice within the Indication Strategy Team.
  • Shape portfolio priorities and resource allocation decisions.
  • Provide executive-ready strategic recommendations supported by analytics and scenario modeling.
  • Mentor high-performing patient marketing talent.
  • Model enterprise mindset, cross-functional influence, and disciplined prioritization.

Core Competencies

• Enterprise Portfolio Optimization
  • Proven ability to maximize total franchise value.
• In-Market Growth Acceleration
  • Track record of driving revenue expansion in competitive markets.
• Patient Engagement & Commercial Strategy
  • Dual-Asset Strategy & Lifecycle Planning
    • Proven ability to maximize total franchise value.
    • Proven track record of driving revenue expansion in competitive markets.
  • Lifecycle Planning
    • Proven ability to maximize total franchise value.
    • Proven track record of driving revenue expansion in competitive markets.
  • Launch Excellence
    • Experience managing multi-asset or multi-indication portfolios strongly preferred.
  • Data-Driven Decision Making & Agile Optimization
    • Experience managing multi-asset or multi-indication portfolios strongly preferred.
  • Executive Influence & Strategic Trade-Off Leadership
    • Experience managing multi-asset or multi-indication portfolios strongly preferred.

  Qualifications

  • 12-15+ years of biopharma commercial experience.
  • Deep patient marketing expertise in specialty or rare disease markets preferred.
  • Demonstrated success driving performance of an in-market brand.
  • Experience managing multi-asset or multi-indication portfolios strongly preferred.
  • MBA or advanced degree preferred.